N-(3-Chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide

Catalog No. :
ACPAMZ854
CAS No. :
478030-85-2
Molecular Formula :
C17H13ClN4O3
Molecular Weight :
356.77

IUPAC Name:N-(3-chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide

N-(3-Chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide
IUPAC NameN-(3-chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide
MDL No.MFCD01316438
Molecular FormulaC17H13ClN4O3
Molecular Weight356.77
SMILESO=C(NC1=CC=CC(Cl)=C1C)C2=CC=C(N3C=CN=C3)C([N+]([O-])=O)=C2
InChI KeyAISMNTAABLIGTD-UHFFFAOYSA-N
SynonymN-(3-CHLORO-2-METHYLPHENYL)-4-(1H-IMIDAZOL-1-YL)-3-NITROBENZENECARBOXAMIDE;N-(3-chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitrobenzamide;Benzamide, N-(3-chloro-2-methylphenyl)-4-(1H-imidazol-1-yl)-3-nitro-
CAS No.478030-85-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPAMZ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAMZ854 route product structure diagram
    ACPAMZ854478030-85-2
Inquiry

2. ACPAMZ854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAMZ854 route product structure diagram
    ACPAMZ854478030-85-2
Inquiry

Comments (0)